Cargando…

A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2

Detalles Bibliográficos
Autores principales: Zhang, Man, Cui, Jing, Shen, Fukui, Ye, Lili, Cheng, Chuanjing, Li, Yang, Zhang, Qiuyang, Niu, Lin, Hou, Yuanyuan, Bai, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787097/
https://www.ncbi.nlm.nih.gov/pubmed/35075789
http://dx.doi.org/10.1002/ctm2.705
_version_ 1784639285880684544
author Zhang, Man
Cui, Jing
Shen, Fukui
Ye, Lili
Cheng, Chuanjing
Li, Yang
Zhang, Qiuyang
Niu, Lin
Hou, Yuanyuan
Bai, Gang
author_facet Zhang, Man
Cui, Jing
Shen, Fukui
Ye, Lili
Cheng, Chuanjing
Li, Yang
Zhang, Qiuyang
Niu, Lin
Hou, Yuanyuan
Bai, Gang
author_sort Zhang, Man
collection PubMed
description
format Online
Article
Text
id pubmed-8787097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87870972022-01-31 A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2 Zhang, Man Cui, Jing Shen, Fukui Ye, Lili Cheng, Chuanjing Li, Yang Zhang, Qiuyang Niu, Lin Hou, Yuanyuan Bai, Gang Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-01-24 /pmc/articles/PMC8787097/ /pubmed/35075789 http://dx.doi.org/10.1002/ctm2.705 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Zhang, Man
Cui, Jing
Shen, Fukui
Ye, Lili
Cheng, Chuanjing
Li, Yang
Zhang, Qiuyang
Niu, Lin
Hou, Yuanyuan
Bai, Gang
A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
title A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
title_full A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
title_fullStr A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
title_full_unstemmed A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
title_short A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2
title_sort novel mode of action for cox‐2 inhibition: targeting atpase domain of hsp90 induces ubiquitin degradation of new client protein cox‐2
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787097/
https://www.ncbi.nlm.nih.gov/pubmed/35075789
http://dx.doi.org/10.1002/ctm2.705
work_keys_str_mv AT zhangman anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT cuijing anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT shenfukui anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT yelili anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT chengchuanjing anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT liyang anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT zhangqiuyang anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT niulin anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT houyuanyuan anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT baigang anovelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT zhangman novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT cuijing novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT shenfukui novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT yelili novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT chengchuanjing novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT liyang novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT zhangqiuyang novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT niulin novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT houyuanyuan novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2
AT baigang novelmodeofactionforcox2inhibitiontargetingatpasedomainofhsp90inducesubiquitindegradationofnewclientproteincox2